A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Part of paid clinical trials in Bakersfield, California.
- Sponsor
- Generate Biomedicines
- Study ID
- NCT07359846
- Phase
- PHASE3
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- GB-0895 — DRUGStudy Drug
- Placebo — DRUGPlacebo
Study Details
The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma that is uncontrolled by inhaled corticosteroids (ICS) and conventional asthma controllers. The study details include: Study treatment: randomized to receive either GB-0895 or placebo administered every 6 months over 52 weeks. Visit frequency: every 1-2 months after the first month.
Key Dates
- Start date
- Jan 20, 2026
- Status verified
- Dec 2025
- Primary completion
- Jan 31, 2029
- Completion
- Jan 31, 2029
Study Design
- Enrollment
- 786 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: GB-0895GB-0895 Subcutaneous (SC) injection
- Placebo Comparator: PlaceboPlacebo Subcutaneous (SC) injection
Primary Outcome Measure
To evaluate the annualized asthma exacerbation rate (AAER) in adult and adolescent subjects with severe uncontrolled asthma. [ Time Frame: From Day 1 (randomization) to Week 52 ]
Central Contacts
- Generate Recruitment888-469-0033
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Research Site 13 | Bakersfield | California | 93301 | |
| Research Site 12 | Inglewood | California | 90301 | |
| Research Site 10 | West Covina | California | 91790 | |
| Research Site 03 | Miami | Florida | 33135 | |
| Research Site 06 | Miami | Florida | 33126 | |
| Research 09 | Orlando | Florida | 32807 | |
| Research Site 01 | Tamarac | Florida | 33321 | |
| Research Site 04 | Tampa | Florida | 33607 | |
| Research Site 05 | Tampa | Florida | 33617 | |
| Research Site 02 | Ypsilanti | Michigan | 48197 | |
| Research Site 11 | Dayton | Ohio | 45424 | |
| Research Site 07 | Sugar Land | Texas | 77479 | |
| Research Site 08 | Williamsburg | Virginia | 23188 |
Find similar trials in Bakersfield, CA
By condition
By specialty
Related Studies
- A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)PHASE3 · Recruiting · Generate Biomedicines · Northridge, California
- A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe AsthmaPHASE2 · Not Yet Recruiting · Kinaset Therapeutics Inc · Lancaster, California
- Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe AsthmaRecruiting · University of Kansas Medical Center · Kansas City, Kansas
- Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe AsthmaRecruiting · Bastiaan Driehuys · Durham, North Carolina